Potential Drug Interaction Between ALXN2040 and Rosuvastatin

In Treatment Period 1, participants will receive a single oral tablet of rosuvastatin in the morning of Day 1. In treatment period 2, on the morning of Day 4, participants will receive a single 20 mg dose of rosuvastatin (co-administered with the morning dose of ALXN2040).

In Treatment Period 2, participants will receive oral tablets of ALXN2040 three times daily on Days 1 through 7.